Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    MELD Score (Original, Pre-2016, Model for End-Stage Liver Disease)

    Calculates the MELD score to quantify end-stage liver disease for transplant planning.
    Favorite

    INSTRUCTIONS

    Note: This is the pre-2016 MELD which does not include serum sodium level, as non-US transplant societies are still using the original MELD formula. The newer MELD Score is listed as “MELD Score”.

    When to Use
    Pearls/Pitfalls
    Why Use

    Determines prognosis and prioritizes receipt of liver transplantation.

    • The MELD was updated in January 2016 and now includes serum sodium level.
    • It is preferable to using the calculator to calculate the MELD as there are several caveats relating to minimum and maximum values assigned in the MELD.
    • Values should be no more than 48 hours old.

    MELD is the standard used by the Organ Procurement and Transplantation Network (OPTN) and determines who is the highest priority to receive liver transplants in the US.

    mg/dL
    mg/dL

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights

    Advice

    The MELD score helps to estimate prognosis for patients with end-stage liver disease, and is used to prioritize transplant recipients.

    Dr. Patrick S. Kamath

    About the Creator

    Patrick S. Kamath, MD, is a professor of gastroenterology and hepatology at the Mayo Clinic in Rochester, Minnesota. His research interests include acute-on-chronic liver failure, nonalcoholic fatty liver disease, polycystic liver disease, Budd-Chiari syndrome and hereditary hemorrhagic telangiectasia. Dr. Kamath is internationally renowned as a leading researcher in hepatology and has also won numerous awards as an educator.

    To view Dr. Patrick S. Kamath's publications, visit PubMed